RP 66784

Drug Profile

RP 66784

Alternative Names: RP 66266

Latest Information Update: 23 Sep 1997

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Aventis
  • Class Antihypertensives; Ischaemic heart disorder therapies; Small molecules
  • Mechanism of Action Potassium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Angina pectoris; Hypertension

Most Recent Events

  • 23 Sep 1997 No-Development-Reported for Angina pectoris in France (Unknown route)
  • 23 Sep 1997 No-Development-Reported for Hypertension in France (Unknown route)
  • 24 Oct 1994 Preclinical development for Angina pectoris in France (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top